A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

NCT06490913 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT06048146 ·Status: COMPLETED ·Phase: NA

Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer

NCT01321957 ·Status: COMPLETED ·Phase: PHASE2

Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

NCT00807911 ·Status: COMPLETED ·Phase: PHASE2

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence

NCT04787341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer

NCT05634590 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer

NCT02141295 ·Status: TERMINATED ·Phase: PHASE2

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

NCT01289821 ·Status: COMPLETED ·Phase: PHASE2

A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases

NCT01260415 ·Status: COMPLETED ·Phase: PHASE2

Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

NCT02705300 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

NCT03487939 ·Status: UNKNOWN ·Phase: PHASE2

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

NCT01652196 ·Status: COMPLETED ·Phase: PHASE2

A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis

NCT02102789 ·Status: RECRUITING ·Phase: PHASE3

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

NCT01515787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer

NCT05954078 ·Status: RECRUITING ·Phase: PHASE3

Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer

NCT00467129 ·Status: UNKNOWN

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

NCT06148402 ·Status: RECRUITING ·Phase: PHASE2

A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

NCT01926769 ·Status: TERMINATED ·Phase: PHASE2

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

NCT01298570 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

NCT01270438 ·Status: WITHDRAWN ·Phase: PHASE2

Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

NCT00719797 ·Status: COMPLETED ·Phase: PHASE3

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

NCT01640405 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

NCT02414009 ·Status: COMPLETED ·Phase: PHASE2

A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors

NCT07104877 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

NCT06662786 ·Status: RECRUITING ·Phase: PHASE3